Sector
PharmaceuticalsOpen
₹80.11Prev. Close
₹80.11Turnover(Lac.)
₹16.8Day's High
₹82Day's Low
₹78.552 Week's High
₹131.752 Week's Low
₹45.06Book Value
₹24.82Face Value
₹10Mkt Cap (₹ Cr.)
141.23P/E
15.82EPS
5.06Divi. Yield
013 May 2025
12:00 AM
Board Meeting
Agenda : Audited Result
6 Jul 2024
12:00 AM
AGM
Announcement Date: 06 Jul, 2024
| Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
Equity Capital | 9.85 | 3.99 | 3.99 | 3.99 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 13.49 | 1.19 | 1.17 | 1.19 |
Net Worth | 23.34 | 5.18 | 5.16 | 5.18 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Revenue | 0 | 0 | 0 | 0 |
yoy growth (%) | 0 | 0 | 0 | 0 |
Raw materials | 0 | 0 | 0 | 0 |
As % of sales | 0 | 0 | 0 | 0 |
Employee costs | -0.06 | -0.09 | -0.09 | -0.08 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Profit before tax | 0 | -0.02 | 0 | 0.01 |
Depreciation | -0.01 | -0.01 | -0.01 | -0.01 |
Tax paid | 0 | -4.69 | 0 | 0 |
Working capital | -5.04 | -0.08 | 0 | -0.08 |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 0 | 0 | 0 | 0 |
Op profit growth | -17.43 | -24.76 | 3.3 | 0.03 |
EBIT growth | -128.85 | 500.97 | -143.8 | -43.2 |
Net profit growth | -121.39 | 326.55 | -227.39 | -36.48 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,647.35 | 92.29 | 3,95,254.45 | 2,000.46 | 0.97 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,493.2 | 78.03 | 1,72,374.06 | 667 | 0.46 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,483.15 | 24.33 | 1,19,795.19 | 1,485.4 | 1.08 | 4,254.47 | 397.41 |
Dr Reddys Laboratories Ltd DRREDDY | 1,326.4 | 20.69 | 1,10,689.83 | 1,200.7 | 0.6 | 5,546.3 | 345.79 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,167.95 | 56.27 | 1,07,213.01 | 474 | 1.01 | 2,385 | 224.33 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Whole-time Director
Sudheer Karna Kankanala
Independent Director
Hemachakrapani Bangaraiahgari
Non Executive Director
Ravikanti Shailaja
Company Sec. & Compli. Officer
MAHENDRA KUMAR
Independent Director
P. Radha Kishore
Non Executive Director
MAGGIDI VENKATESH
Independent Director
Julius Paul Reinhard Paschke
House No 4-50/1 Sy No 134 132,
Block B 8th Floor Flat No 801,
Telangana - 500032
Tel: -
Website: http://www.miel.co.in
Email: co@miel.co.in
Beetal House 3rd Flr,
Behind Local Shp Cen, Nr Dada Harsukh Das,
New Delhi - 110062
Tel: 91-11-29961281-82
Website: www.beetalfinancial.com
Email: beetal@beetalfinancial.com
Summary
Macro International Limited (Formerly known Macro (International) Exports Limited) was incorporated in Aug.93. The Company was promoted by the Kanpur based business house of Parasrampurias. The Compan...
Read More
Reports by Macro International Ltd
What is the Astal Laboratories Ltd share price today?
What is the Market Cap of Astal Laboratories Ltd?
What is the PE and PB ratio of Astal Laboratories Ltd?
What is the 52 Week High and Low of Astal Laboratories Ltd?
What is the CAGR of Astal Laboratories Ltd?
What is the shareholding pattern of Astal Laboratories Ltd?
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.